Bikash khadka | Medicine and Dentistry | Best Researcher Award

Dr. Bikash khadka | Medicine and Dentistry | Best Researcher Award

Dr. Bikash khadka , Nepal Mediciti , Nepal

Dr. Bikash Khadka is a dedicated anesthesiologist from Lalitpur, Kathmandu, Nepal, with extensive experience in critical care and perioperative medicine. He earned his MD in Anesthesiology from Lumbini Medical College, affiliated with Kathmandu University, in 2018, after completing his MBBS at Kathmandu University School of Medical Sciences in 2012. Dr. Bikash Khadka currently serves as a Junior Consultant Anesthesiologist at Nepal Mediciti Hospital, where he manages a 32-bed mixed ICU and conducts anesthesia for various surgeries. Passionate about medical education, he has also served as a Lecturer at Lumbini Medical College. His research focuses on anesthesia techniques, critical care, and perioperative safety, with numerous published articles in peer-reviewed journals. He is proficient in advanced airway management, regional blocks, and critical patient care. Dr. Bikash  Khadka actively participates in medical workshops and conferences to stay updated in his field.

Publication Profile

Scopus

Work Experience

Dr. Bikash Khadka has been a Junior Consultant Anesthesiologist at Nepal Mediciti Hospital since August 2019, where he manages a 32-bed mixed ICU and provides anesthesia for diverse surgeries. From November 2018 to August 2019, he worked as a Lecturer at Lumbini Medical College, teaching anesthesiology to medical students. As a Resident Doctor (2015-2018) at the same institution, he performed pre-anesthetic assessments, anesthesia conduction, ICU management, and supervised junior residents. His responsibilities included emergency surgeries, obstetric analgesia, and critical care. From September 2013 to March 2014, he was a Medical Officer at Alka Hospital, providing emergency care. His experience spans specialized anesthesia services, resuscitation, and managing patients across various surgical and ICU settings.

Education and Training

Dr. Bikash Khadka earned his MD in Anesthesiology from Lumbini Medical College, affiliated with Kathmandu University, from 2015 to 2018. Prior to that, he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Kathmandu University School of Medical Sciences between 2008 and 2012. During his medical education, he acquired extensive theoretical knowledge and hands-on experience, laying the foundation for his career in anesthesiology and critical care. His education focused on pre-anesthetic assessment, anesthesia conduction, ICU management, and patient care during complex surgical procedures. Dr. Bikash Khadka also completed significant training, including ACLS, BLS, airway management, and acute care ultrasound workshops, strengthening his proficiency in both clinical and emergency care. His commitment to continual learning is reflected in his active participation in national conferences and specialized courses.

Awards and Training

Dr. Bikash Khadka has attended various prestigious conferences and workshops, including the 17th National Conference of the Society of Anesthesiologists of Nepal (SANCON) in 2016. He participated in specialized workshops like the Difficult Airway Workshop and Acute Care Ultrasound Workshop. He holds certifications in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS), showcasing his dedication to critical care excellence. His commitment to academic excellence is evident through his lecturer role and involvement in training junior residents. Dr. Bikash Khadka’s clinical expertise and research contributions have established him as a respected professional in anesthesiology and critical care in Nepal.

Research Focus

Dr. Bikash Khadka’s research focuses on anesthesiology, critical care, and perioperative management. His interests include optimizing patient outcomes in ICU settings, managing complex airway cases, and preventing anesthesia-related complications. He has contributed to research on rare medical conditions, such as Boerhaave syndrome and post-COVID-19 vaccine complications. Dr. Bikash khadka is also interested in comparative studies on pharmacological agents to improve surgical outcomes, such as using dexmedetomidine and dexamethasone for postoperative nausea prevention. His work often explores innovative approaches to regional anesthesia, patient safety, and critical care protocols. His systematic reviews and case reports provide valuable insights into anesthesia practice and patient management.

Publication Top Notes 📚

Role of pre-operative counseling with NSQIP surgical risk calculator in the surgical patients

Authors: Khadka, B., Sharma, A., Bhattarai, P.R., Rayamajhi, B., Adhikari, H.

Journal: Surgery Open Science

Year: 2024

Volume: 18, pp. 11–16

Citations: 0

Pyopericardium progressing to cardiac tamponade in a patient with dengue fever

Authors: Khadka, B., Khanal, K., Regmi, A., KC, S., Nepal, R.

Journal: IDCases

Year: 2024

Volume: 36, Article e01996

Citations: 0

Removing knotted or stuck epidural catheters: a systematic review of case reports

Authors: Khadka, B., Sharma, A., Regmi, A., Ghimire, A., Bhattarai, P.R.

Journal: Anesthesia and Pain Medicine

Year: 2023

Volume: 18(3), pp. 315–324

Citations: 1

A rare case of Boerhaave syndrome with cervico-thoracic esophageal junction rupture causing bilateral empyema; case report from Nepal

Authors: Khadka, B., Khanal, K., Dahal, P., Adhikari, H.

Journal: International Journal of Surgery Case Reports

Year: 2023

Volume: 105, Article 108018

Citations: 2

Post COVID-19 vaccine Guillain-Barré syndrome

Authors: Khadka, B., Khanal, K.

Journal: Journal of Nepal Health Research Council

Year: 2022

Volume: 19(4), pp. 852–854

Citations:

 

 

 

 

Javad Sajedianfard | Dentistry Award | Best Researcher Award

Prof. Javad Sajedianfard | Dentistry Award | Best Researcher Award

Prof. Javad Sajedianfard, Shiraz University, Iran

Prof. Javad Sajedianfard is a dedicated academic and researcher in veterinary medicine and physiology. He completed his DVM at Shiraz University in 1991 and later earned his Ph.D. in physiology from Tarbiat Modarres University in 2003. He holds a permanent veterinary practice license and has participated in various workshops on neuroscience, educational methods, and statistical analysis. Prof. Sajedianfard has held significant academic positions, including Vice Chancellor of the School of Veterinary Medicine at Shiraz University. A member of the Physiology and Pharmacology Society, he also contributes to the editorial board of the Iranian Journal of Medical Sciences.

 

Publication profile

Google Scholar

Education 🎓

Prof. Javad Sajedianfard has a solid educational background in veterinary medicine and physiology. He started his academic journey with a junior certification in English in 1978, followed by completing high school in 1980 at Salman-Parsi High School in Shiraz, Iran. In 1991, he graduated from the Veterinary Medicine School at Shiraz University. Over the years, Prof. Sajedianfard has actively participated in several workshops, including those focused on educational methods, neuroscience physiology, statistical analysis using SPSS, psychological health, and educational administration. His continuous professional development highlights his commitment to education and research in veterinary medicine and related fields.

Professional Certification and Memberships 📜

In 1991, Prof. Sajedianfard obtained a permanent license to practice veterinary medicine in Iran, establishing his credentials in the field. He has also been involved in various professional organizations. He was a member of the Shiraz University Informatics Specialist Committee from 1996 to 1998 and joined the International Brain Research Organization (IBRO) from 2002 to 2004. Since 2007, he has been a member of the Physiology and Pharmacology Society. Additionally, he has served as a member of the Basic Sciences specialist group of the Ministry of Science, Research, and Technology since 2018, and has been on the editorial board of the Iranian Journal of Medical Sciences since 2019. His active participation in these organizations demonstrates his commitment to advancing veterinary medicine and physiology.

Professional Services and Academic Positions 🏛️

Prof. Sajedianfard has extensive teaching and administrative experience. He began teaching pharmacology at Kazeroon Azad Islamic University in 1991 and served as an expert in the Fars Province Veterinary Network from 1992 to 1994. In 1994, he joined the academic staff at the Department of Pharmacology, School of Veterinary Medicine, Shiraz University, where he continued to contribute to academia and research. In 1999, he shifted to the Department of Physiology, where he pursued his Ph.D. in physiology at Tarbiat Modarres University, Tehran, and later became an assistant professor in 2003. He also held administrative roles, including head of the Basic Sciences Department (2003-2005) and vice chancellor of the School of Veterinary Medicine (2005-2007 and 2014-2018). Prof. Sajedianfard’s academic and administrative leadership highlights his dedication to advancing the field of veterinary medicine.

Publication Top Notes 

  • The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats 📊🦠
    Cited by: 98, Year: 2016
  • Effect of adding inulin on microbial and physicochemical properties of low fat probiotic yogurt 🍶🦠
    Cited by: 95, Year: 2011
  • Effect of Probiotic Bacillus Coagulans and Lactobacillus Plantarum on Alleviation of Mercury Toxicity in Rat 🐀💊
    Cited by: 69, Year: 2017
  • Effect of Probiotics Bacillus coagulans and Lactobacillus plantarum on Lipid Profile and Feces Bacteria of Rats Fed Cholesterol-Enriched Diet 🐁🥚
    Cited by: 59, Year: 2019
  • Protective effects of synbiotic diets of Bacillus coagulans, Lactobacillus plantarum and inulin against acute cadmium toxicity in rats 🧪🐀
    Cited by: 55, Year: 2017
  • In vivo measurement of noradrenaline in the locus coeruleus of rats during the formalin test: a microdialysis study 🧠🧬
    Cited by: 49, Year: 2005
  • The effects of probiotic, prebiotic and synbiotic diets containing Bacillus coagulans and inulin on rat intestinal microbiota 🦠🐀
    Cited by: 45, Year: 2015
  • Study of patient’s injuries by stingrays, lethal activity determination and cardiac effects induced by Himantura gerrardi venom 🦈💉
    Cited by: 33, Year: 2009
  • Effects of Camphor on Sexual Behaviors in Male Rats: Effects of camphor on sexual behaviors 🌿🐀
    Cited by: 33, Year: 2006
  • Impact of synbiotic diets including inulin, Bacillus coagulans and Lactobacillus plantarum on intestinal microbiota of rat exposed to cadmium and mercury 🌿🐭
    Cited by: 24, Year: 2015
  • The effect of intra-cerebroventricular injection of insulin on the levels of monoamines on the raphe magnus nucleus of non-diabetic and short-term diabetic rats in the formalin test 💉🧠
    Cited by: 20, Year: 2019
  • The effects of a hydroalcoholic extract of silymarin on serum lipids profiles in streptozotocin-induced diabetic rats 🌿💊
    Cited by: 19, Year: 2014


Conclusion 🏆

Prof. Javad Sajedianfard’s extensive educational background, professional certifications, and active membership in various scientific societies, coupled with his significant academic and administrative roles, make him a strong candidate for the Research for Best Researcher Award. His contributions to veterinary medicine, physiology, and educational leadership demonstrate his dedication to advancing scientific knowledge and training the next generation of professionals. Prof. Sajedianfard’s career reflects a sustained commitment to excellence in research, teaching, and service, positioning him as a suitable nominee for recognition in the field of veterinary and medical sciences.

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

  1. Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidis’s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

 

Research focus
The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. 🩺💉🔬

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease